Clinical News

RCGP IBD Toolkit Official Launch

Tuesday, 22 August 2017 13:52

The Royal College of General Practitioners (RCGP), in partnership with Crohn's and Colitis UK, has launched a IBD toolkit for GPs and healthcare professionals.

RCGP's Clinical Champion for Inflammatory Bowel Disease, Dr Kevin Barrett, who developed the toolkit together with the patient representative Rachel Fowler and the project's steering group, comments "Inflammatory Bowel Disease affects at least 1 in 250 of the UK population and the prevalence is rising. Early diagnosis, managing flares, supporting patients to stay well and monitoring long-term risks are all vital aspects of care. The RCGP's IBD toolkit is designed to help GPs better identify and manage IBD, and provide education resources for healthcare professionals and patients alike."

Jackie Glatter, Health Service Development Manager at Crohn's and Colitis UK said, "GPs play a really important role in identifying people with suspected IBD and supporting these patients throughout their lives, in conjunction with the secondary care team. We are delighted to be working in partnership with the RCGP to provide resources for GPs and to highlight the information and support we can provide for people with IBD."

The IBD toolkit ( has been produced as part of the College's Spotlight Project on inflammatory bowel disease, which will be delivering a number of free workshops and further learning resources for GPs throughout 2017/2018.

For more information on the work of the College's Clinical Innovation and Research Centre, and for tools to support your practice, please visit

PHE Notice - Re: Shortage of hepatitis B vaccines - recommendations for national clinical directors

Wednesday, 09 August 2017 11:22

Dr. Mary Ramsay and Dr Sema Mandal
Immunisation, Hepatitis, Blood Safety and Countermeasures Response

There is a global shortage of hepatitis B vaccine which is currently impacting severely on the UK supply. The situation is particularly critical during August but limitations on supply are likely to continue until early 2018. To ensure that stock is available for those individuals at highest and most immediate risk of exposure to hepatitis B, Public Health England (PHE) has developed temporary recommendations to support clinicians undertaking an individual risk assessment.

PHE and Department of Health (DH) have been working with both vaccine manufacturers to institute ordering restrictions according to customer type. The allocation is based on an agreed assessment of the proportion of vaccines used by that provider type for individuals in the highest priority groups. As a consequence, some providers may not be able to order any stock and others will have limits applied to their orders. A mechanism will be in place, however, to allow for exceptional orders if there is an urgent and immediate need for an individual following an individual risk assessment.

NHS Hospital Trusts will get the highest allocation, but it has been agreed with the BMA's General Practitioners Committee that general practice will not be able to order any adult hepatitis B vaccine stock until further notice. Because of this, patients requiring post-exposure hepatitis B vaccination will be referred to urgent care or Accident and Emergency based in NHS trusts for an assessment. In addition, specialist services such as liver services, who may normally request that GPs offer hepatitis B vaccination to their patients should note that the GP may not be able to meet this request.

To sustain supply for those at greatest need, all services are being asked to:

  • ensure that clinicians are aware of the temporary recommendations on prioritising vaccines
  • only order essential vaccine stock (small amounts more frequently) and avoid stockpiling
  • coordinate and monitor stock usage across the service to ensure that scarce stock is being used responsibly
  • accept and use alternative products including combined hepatitis A and B vaccines, and other presentations (e.g. multi-dose packs)

The full list of recommendations may be downloaded below:


Survey: Use of therapeutic drug monitoring for biologics in IBD

Friday, 04 August 2017 13:17

We are hoping to gain a better understanding of practice patterns with regards to the use of therapeutic drug monitoring (TDM) for infliximab and adalimumab in IBD. This short questionnaire is designed to investigate how widely TDM is used as well as how the results are interpreted. We would be very grateful if you would take 4-5 minutes of your time to complete it and all responses will be collected anonymously.

BSG Election 2017: Endoscopy

Wednesday, 02 August 2017 12:23

Due to the appointment of George Webster as Vice-President Endoscopy of the BSG, a position has become available for an elected member of the BSG Endoscopy Section Committee. Nominations for members to stand in these elections will open Tuesday 1st August 2017 and will close on 17:00 Friday 8th September 2017.

Please note only full members of the BSG Endoscopy Section will be eligible to stand and vote in the final ballot. Changing Section membership is not allowed once elections are underway.

If you are nominating someone for a position on the BSG Endoscopy Section Committee then please ask your nominee for a short statement setting out why members should vote for them (250 words approx.). Candidates who do not send in their personal statement by the end of the nomination period will not be eligible to stand in the election. The forms should be emailed to Mr Christopher O'Shea ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ). This information will appear in the online voting system.

In order to be nominated you MUST have already joined the relevant Clinical Section as a member. If you have not already done this, please do so by logging in to the BSG website and entering the Sections to which you want to belong or by emailing your request to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

  Download nomination form

Page 2 of 17